# Waters Corporation (WAT)

- Sector: Healthcare · Industry: Diagnostics and Research
- SEC CIK: 0001000697 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001000697))
- Full page: https://inspectstocks.com/stocks/wat
- Data as of: price 2026-09-25; newest filing used 2026-08-11; latest fiscal period ended 2026-07-04

## Grade

**B** on the growth-and-cash rubric, 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $4.6B | $3B |
| Revenue growing recently | passed | $4.6B | $3.2B |
| Free cash flow positive | passed | $539.8M |  |
| Free cash flow growing overall | passed | $539.8M | $435.7M |
| Free cash flow growing recently | failed | $539.8M | $619.6M |

Business quality (the + / − mark): 3 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 3.6% |  |
| Healthy profit margin | failed | 3.6% |  |
| Strong operating margin | failed | 7.1% |  |
| Good return on equity | failed | 6.5% |  |
| Debt under control | passed | 0.40 |  |
| Turns sales into cash | passed | 13.0% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $4.6B |
| Net income, trailing twelve months | $166.1M |
| Free cash flow, trailing twelve months | $539.8M |
| Net margin | 3.6% |
| Operating margin | 7.1% |
| Return on equity | 6.5% |
| Debt to equity | 0.40 |
| Diluted EPS, trailing twelve months | $4.01 |
| Share price | $433.54 |
| Market value | $42.6B |
| Price / earnings | 108.1x |
| Price / sales | 9.2x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/wat)
- [Financial statements](https://inspectstocks.com/stocks/wat/financials)
- [Competitors](https://inspectstocks.com/stocks/wat/peers)
- [Earnings](https://inspectstocks.com/stocks/wat/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.